Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
The historical rank and industry rank for Advanced Enzyme Technologies's Return-on-Tangible-Asset or its related term are showing as below:
NSE:ADVENZYMES'
s Return-on-Tangible-Asset Range Over the Past 10 Years
Min: 10.86 Med: 17.37 Max: 30.9
Current: 12.59
During the past 13 years, Advanced Enzyme Technologies's highest Return-on-Tangible-Asset was 30.90%. The lowest was 10.86%. And the median was 17.37%.
NSE:ADVENZYMES's Return-on-Tangible-Asset is ranked better than 90.39% of 1623
companies
in the Chemicals industry
Industry Median: 3.62
vs NSE:ADVENZYMES: 12.59
Return-on-Tangible-Asset measures the rate of return on the average total tangible assets (total assets minus intangible assets). Tangible means physical in nature. Intangible Assets are assets that are not physical in nature, and typically "derive their value from legal or intellectual rights." Return-on-Tangible-Asset measures a firm's efficiency at generating profits from its tangible assets. It shows how well a company uses what it has to generate earnings. Return-on-Tangible-Assets can vary drastically across industries. Therefore, Return-on-Tangible-Asset should not be used to compare companies in different industries.
Be Aware
Like ROE and ROA, Return-on-Tangible-Asset is calculated with only 12 months data. Fluctuations in the companys earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective. Return-on-Tangible-Asset can be affected by events such as stock buyback or issuance, and by a companys tax rate and its interest payment. Return-on-Tangible-Asset may not reflect the true earning power of the assets. A more accurate measurement is ROC % (ROC).
Many analysts argue the higher return the better. Buffett states that really high Return-on-Tangible-Asset may indicate vulnerability in the durability of the competitive advantage.
Advanced Enzyme Technologies Return-on-Tangible-Asset Related Terms
Advanced Enzyme Technologies Return-on-Tangible-Asset Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
NSE:ADVENZYMES vs LIN, SHW, ECL: Return-on-Tangible-Asset Comparison
For the Specialty Chemicals subindustry, Advanced Enzyme Technologies's Return-on-Tangible-Asset, along with its competitors' market caps and Return-on-Tangible-Asset data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Advanced Enzyme Technologies Return-on-Tangible-Asset vs Chemicals Industry
For the Chemicals industry and Basic Materials sector, Advanced Enzyme Technologies's Return-on-Tangible-Asset distribution charts can be found below:
* The bar in red indicates where Advanced Enzyme Technologies's Return-on-Tangible-Asset falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual Return-on-Tangible-Asset, the net income of the last fiscal year and the average total tangible assets over the fiscal year are used. In calculating the quarterly data,
the Net Income data used here is four times the quarterly (Jun. 2026) net income data.
What does a Return-on-Tangible-Asset of 10.43% mean?
Advanced Enzyme Technologies (NSE:ADVENZYMES) has a Return-on-Tangible-Asset of 10.43% as of Jun. 2026. Return on tangible assets is the ratio of current-period net income to average two-period tangible assets. View historical data on Advanced Enzyme Technologies and its competitors. This is 40% below median its historical median of 17.37. Over the past decade, Advanced Enzyme Technologies' Return-on-Tangible-Asset has ranged from 10.86 to 30.90. According to the industry distribution chart, Advanced Enzyme Technologies ranks #156 out of 1623 companies in the Chemicals industry, placing it in the top 9.6%.
Is Advanced Enzyme Technologies' Return-on-Tangible-Asset too high?
Advanced Enzyme Technologies' current Return-on-Tangible-Asset of 10.43% is 40% below median its 10-year median of 17.37. Over the past 10 years, this metric has ranged from a low of 10.86 to a high of 30.90. The Chemicals industry median Return-on-Tangible-Asset is 3.62. Advanced Enzyme Technologies' value of 10.43% is 188.1% above this industry median. Based on the distribution chart, Advanced Enzyme Technologies ranks #156 out of 1623 companies in the Chemicals industry, which is in the top quartile — a strong position relative to peers. Overall, Advanced Enzyme Technologies has a GF Score™ of 88/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Advanced Enzyme Technologies' Return-on-Tangible-Asset compare to LIN and SHW?
According to the Chemicals industry distribution chart, Advanced Enzyme Technologies ranks #156 out of 1623 companies for Return-on-Tangible-Asset. This places Advanced Enzyme Technologies in the top 10% of its industry — outperforming the majority of peers. The industry median Return-on-Tangible-Asset is 3.62. Advanced Enzyme Technologies' value of 10.43% is 188.1% above this benchmark. Historically, Advanced Enzyme Technologies' own Return-on-Tangible-Asset has ranged from 10.86 to 30.90 over the past decade. While the company's 10-year median is 17.37 vs. the industry median of 3.62, Advanced Enzyme Technologies has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Return-on-Tangible-Asset for a Chemicals company?
The median Return-on-Tangible-Asset among Chemicals companies is 3.62, based on 1,623 companies in the industry. Companies in the top quartile (top 25%) have a Return-on-Tangible-Asset significantly above this median, while those in the bottom quartile fall well below. However, Return-on-Tangible-Asset should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Advanced Enzyme Technologies's current Return-on-Tangible-Asset of 10.43% is 188.1% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Return-on-Tangible-Asset mean?
A high Return-on-Tangible-Asset can signal that a stock is expensive relative to its fundamentals. Return on tangible assets is the ratio of current-period net income to average two-period tangible assets. View historical data on Advanced Enzyme Technologies and its competitors. For the Chemicals industry, the median Return-on-Tangible-Asset is 3.62 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Advanced Enzyme Technologies's current Return-on-Tangible-Asset is 10.43%, which is 40% below median its own 10-year median of 17.37. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Advanced Enzyme Technologies stock overvalued right now?
Based on GuruFocus' analysis, Advanced Enzyme Technologies (NSE:ADVENZYMES) is currently considered Modestly Undervalued. The stock's GF Value™ is ₹413.16, compared to a current price of ₹293.40 — trading 29% below its estimated fair value. The current Return-on-Tangible-Asset is 10.43%, which is 40% below median its 10-year median of 17.37 and 188.1% above the Chemicals industry median of 3.62. Advanced Enzyme Technologies' overall GF Score™ is 88/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Return-on-Tangible-Asset calculated?
Return-on-Tangible-Asset is calculated from a company's financial statements. For Advanced Enzyme Technologies (NSE:ADVENZYMES), the current Return-on-Tangible-Asset is 10.43% as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Advanced Enzyme Technologies (NSE:ADVENZYMES) Overvalued in 2026?
Based on GuruFocus' analysis, Advanced Enzyme Technologies stock appears to be undervalued.
The current stock price of ₹293.40 is trading 29% below its estimated GF Value™ of ₹413.16.
GuruFocus considers Advanced Enzyme Technologies to be Modestly Undervalued.
Key valuation signals for NSE:ADVENZYMES:
Return-on-Tangible-Asset: 10.43% (40% below median its 10-year median of 17.37)
GF Value™: ₹413.16 vs. price of ₹293.40 (29% below fair value)
Industry Position: 188.1% above the Chemicals median (#156 of 1623)
No single metric tells the full story. See the NSE:ADVENZYMES stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Advanced Enzyme Technologies Ltd is an Indian company engaged in research activities to manufacture and sell enzymes. The company operates only in one business segment, viz., manufacturing and sales of enzymes. The company offers enzymes for human healthcare and nutrition, animal nutrition, food processing, and non-food processing. Some of the products offered by the company are serratiopeptidase, fungal lipase, papain, hemicellulose, and digegrain, among others. Geographically, the entity operates in India, Europe, the USA, Asia, and other countries, of which a majority of the revenue is derived from India.
88GF Score
Get the complete analysis for NSE:ADVENZYMES
Return-on-Tangible-Asset is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NSE:ADVENZYMES has been successfully added to your 
